Followers | 46 |
Posts | 3734 |
Boards Moderated | 0 |
Alias Born | 09/18/2018 |
Monday, April 15, 2024 3:54:05 PM
These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue
to realize its assets and discharge its liabilities in the normal course of business. However, the accompanying financialstatements
reflect that the Company hasincurred significant operating losses and has a deficit in shareholders’ equity. These factors raise
substantial doubt regarding the Company’s ability to continue as a going concern. The continuation of the Company as a going
concern is dependent upon the continued financial supportfrom its shareholders, the ability of the Company to obtain necessary
equity financing to continueoperations. At February 29, 2024, the Company has accumulated losses of $4,976,671 since
inception. These consolidated financial statements include write off of assets acquired that are no longer useful and have no
value.
before. this had both how much debt is PRESENTLY owned, followed by the losses since inception. This time is doesn't have debt presently owned.
later it shows a 23400 loan payed off short term.
indeed, the last 2B diluted was alex benz diluting mroe of our stock through convertibles. no sign yet of how UBQU has "acquired" innovative outcomes. but at this point, I'm still not worried. we only aren't moving up because the market is collapsing in real time, the algos still own us. but whoever got those 10M in sells to 000001 (citadel maybe) will love to have (make?) this stock run.
it might happen before, or after, the market collapse....imo always imo.....but the filing to me and its omission of real debt (perhaps its paid off?) is quite interesting.
Recent UBQU News
- Ubiquitech Software Corporation Retains Vitello Capital Ltd. to Aid Strategic Planning and Assess Global Acquisition Opportunities • InvestorsHub NewsWire • 10/11/2023 12:09:01 PM
- Ubiquitech Reports Convertible Debt Forgiveness in Excess of $1,000,000 • InvestorsHub NewsWire • 06/22/2023 12:44:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM